Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Greed Is Good who wrote (1341)	5/9/1999 2:08:00 PM
From: Alex Glavinos	Read Replies (1) \| Respond to of 1510

Greed is Good, I think we will see more positive mention about Remune Therapy, when the Thai Government approves the use. I suspect we should hear about approval shortly. IMHO Remune is very close. trinitygroups.com The Phase III trials in the U.S. should be completed 6 months from now. Hopefully, FDA approval should come earlier. Other research will continue and you will hear about many new experimental drugs. None of which have entered the FDA trial phases. When new drugs are in their final approval stages, you don't hear too much hype. I've held on for two years, I can hold on a bit longer. If and when approval comes, you'll hear and read a great deal about Remune.